Cambridge Healthtech Institute’s 4th Annual
Bioprocess Data Management and Analysis
( 生物製程數據管理和分析 )
Advancing Bioprocessing Through Instrumentation, Characterization, Control, and Analytics
Part of the Process Technologies & Purification pipeline
The biopharmaceutical industry is meeting increasing demands and costs for biotherapeutics through process optimization. Data from advanced instrumentation through sampling techniques, new sensor technologies, and analyzers have emerged to monitor both upstream and downstream processes. When well-prepared and analyzed, this data leads to process knowledge, process control, and continuous improvement, resulting in greater speed, quality, and economy. Cambridge Healthtech Institute’s 4th Annual Bioprocess Data Management and Analysis conference addresses statistical analysis strategies allowing for optimized and informed control of bioprocessing.
BIOTHERAPEUTIC ENGINEERING AND ANALYTICS
Platformization of Multi-Specific Protein Engineering: Learning from High-Throughput Screening Data
Norbert Furtmann, PhD, Head of Data Lab, High Throughput Biologics, Sanofi-Aventis Deutschland GmbH
E2E Biologics Platform - From Discovery to Development
Yuan Lin, Biologics Solution Lead, Pfizer Inc.
How Can Systems Biology Tools Facilitate a Cost-Effective Upstream Process Development in the Biopharmaceutical Industry?
Anne Richelle, PhD, Senior Specialist - Metabolic Modeling, GSK, Belgium
Khandaker Siddiquee, PhD, Principal Scientist, Biologic Process Design, Abbott Diagnostic Division, Abbott Laboratories